 | • レポートコード：MRC2-11QY04112 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、91ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥585,000 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥877,500 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,170,000 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は骨粗鬆症治療薬のグローバル市場について調査・分析したレポートです。種類別（ビスフォスフォネート、ホルモン、ラネル酸ストロンチウム、ラロキシフェン、デノスマブ、その他）市場規模、用途別（病院薬局、オンライン薬局、小売薬局）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別骨粗鬆症治療薬の競争状況、市場シェア ・世界の骨粗鬆症治療薬市場：種類別市場規模 2015年-2020年（ビスフォスフォネート、ホルモン、ラネル酸ストロンチウム、ラロキシフェン、デノスマブ、その他） ・世界の骨粗鬆症治療薬市場：種類別市場規模予測 2021年-2026年（ビスフォスフォネート、ホルモン、ラネル酸ストロンチウム、ラロキシフェン、デノスマブ、その他） ・世界の骨粗鬆症治療薬市場：用途別市場規模 2015年-2020年（病院薬局、オンライン薬局、小売薬局） ・世界の骨粗鬆症治療薬市場：用途別市場規模予測 2021年-2026年（病院薬局、オンライン薬局、小売薬局） ・北米の骨粗鬆症治療薬市場分析：米国、カナダ ・ヨーロッパの骨粗鬆症治療薬市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの骨粗鬆症治療薬市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の骨粗鬆症治療薬市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの骨粗鬆症治療薬市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Warner Chilcott、Merck & Co.、Roche、Novartis、Ono、Astellas Pharma、Procter & Gamble、Sumitomo Pharmaceuticals、Servier、Eli Lilly、Pfizer、Amgen、Chugai ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Osteoporosis is a silent epidemic and as per the WHO declarations, it is a priority health issue. Osteoporosis is a disruption of bone architecture and decrease in bone mass, leading to a number of complications including increased chances of bone fractures and reduced bone strength. The most common sites of osteoporosis are the spine, hip and forearm, although it also affects other body parts.
The osteoporosis therapeutic market has become very competitive due to the high number of new drug approvals, although the majority of them are incremental innovations of existing therapies. Competition is fierce, particularly among bisphosphonates and selective estrogen receptor modulators (SERMs), which are mostly used as first-line therapy and dominate the treatment market for osteoporosis patients.
Market Analysis and Insights: Global Osteoporosis Therapeutics Market
The global Osteoporosis Therapeutics market size is projected to reach US$ 10660 million by 2026, from US$ 10420 million in 2020, at a CAGR of 2.2%% during 2021-2026.
Global Osteoporosis Therapeutics Scope and Market Size
Osteoporosis Therapeutics market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Osteoporosis Therapeutics market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Warner Chilcott
Merck & Co.
Roche
Novartis
Ono
Astellas Pharma
Procter & Gamble
Sumitomo Pharmaceuticals
Servier
Eli Lilly
Pfizer
Amgen
Chugai
Market segment by Type, the product can be split into
Bisphosphonates
Hormones
Strontium Ranelate
Raloxifene
Denosumab
Others
Market segment by Application, split into
Hospital Pharmacies
Online Pharmacies
Retail Pharmacies
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Osteoporosis Therapeutics Revenue
1.4 Market by Type
1.4.1 Global Osteoporosis Therapeutics Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Bisphosphonates
1.4.3 Hormones
1.4.4 Strontium Ranelate
1.4.5 Raloxifene
1.4.6 Denosumab
1.4.7 Others
1.5 Market by Application
1.5.1 Global Osteoporosis Therapeutics Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Online Pharmacies
1.5.4 Retail Pharmacies
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Osteoporosis Therapeutics Market Perspective (2015-2026)
2.2 Global Osteoporosis Therapeutics Growth Trends by Regions
2.2.1 Osteoporosis Therapeutics Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Osteoporosis Therapeutics Historic Market Share by Regions (2015-2020)
2.2.3 Osteoporosis Therapeutics Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Osteoporosis Therapeutics Market Growth Strategy
2.3.6 Primary Interviews with Key Osteoporosis Therapeutics Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Osteoporosis Therapeutics Players by Market Size
3.1.1 Global Top Osteoporosis Therapeutics Players by Revenue (2015-2020)
3.1.2 Global Osteoporosis Therapeutics Revenue Market Share by Players (2015-2020)
3.1.3 Global Osteoporosis Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Osteoporosis Therapeutics Market Concentration Ratio
3.2.1 Global Osteoporosis Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Osteoporosis Therapeutics Revenue in 2019
3.3 Osteoporosis Therapeutics Key Players Head office and Area Served
3.4 Key Players Osteoporosis Therapeutics Product Solution and Service
3.5 Date of Enter into Osteoporosis Therapeutics Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Osteoporosis Therapeutics Historic Market Size by Type (2015-2020)
4.2 Global Osteoporosis Therapeutics Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Osteoporosis Therapeutics Market Size by Application (2015-2020)
5.2 Global Osteoporosis Therapeutics Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Osteoporosis Therapeutics Market Size (2015-2020)
6.2 Osteoporosis Therapeutics Key Players in North America (2019-2020)
6.3 North America Osteoporosis Therapeutics Market Size by Type (2015-2020)
6.4 North America Osteoporosis Therapeutics Market Size by Application (2015-2020)
7 Europe
7.1 Europe Osteoporosis Therapeutics Market Size (2015-2020)
7.2 Osteoporosis Therapeutics Key Players in Europe (2019-2020)
7.3 Europe Osteoporosis Therapeutics Market Size by Type (2015-2020)
7.4 Europe Osteoporosis Therapeutics Market Size by Application (2015-2020)
8 China
8.1 China Osteoporosis Therapeutics Market Size (2015-2020)
8.2 Osteoporosis Therapeutics Key Players in China (2019-2020)
8.3 China Osteoporosis Therapeutics Market Size by Type (2015-2020)
8.4 China Osteoporosis Therapeutics Market Size by Application (2015-2020)
9 Japan
9.1 Japan Osteoporosis Therapeutics Market Size (2015-2020)
9.2 Osteoporosis Therapeutics Key Players in Japan (2019-2020)
9.3 Japan Osteoporosis Therapeutics Market Size by Type (2015-2020)
9.4 Japan Osteoporosis Therapeutics Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Osteoporosis Therapeutics Market Size (2015-2020)
10.2 Osteoporosis Therapeutics Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Osteoporosis Therapeutics Market Size by Type (2015-2020)
10.4 Southeast Asia Osteoporosis Therapeutics Market Size by Application (2015-2020)
11 India
11.1 India Osteoporosis Therapeutics Market Size (2015-2020)
11.2 Osteoporosis Therapeutics Key Players in India (2019-2020)
11.3 India Osteoporosis Therapeutics Market Size by Type (2015-2020)
11.4 India Osteoporosis Therapeutics Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Osteoporosis Therapeutics Market Size (2015-2020)
12.2 Osteoporosis Therapeutics Key Players in Central & South America (2019-2020)
12.3 Central & South America Osteoporosis Therapeutics Market Size by Type (2015-2020)
12.4 Central & South America Osteoporosis Therapeutics Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Warner Chilcott
13.1.1 Warner Chilcott Company Details
13.1.2 Warner Chilcott Business Overview
13.1.3 Warner Chilcott Osteoporosis Therapeutics Introduction
13.1.4 Warner Chilcott Revenue in Osteoporosis Therapeutics Business (2015-2020))
13.1.5 Warner Chilcott Recent Development
13.2 Merck & Co.
13.2.1 Merck & Co. Company Details
13.2.2 Merck & Co. Business Overview
13.2.3 Merck & Co. Osteoporosis Therapeutics Introduction
13.2.4 Merck & Co. Revenue in Osteoporosis Therapeutics Business (2015-2020)
13.2.5 Merck & Co. Recent Development
13.3 Roche
13.3.1 Roche Company Details
13.3.2 Roche Business Overview
13.3.3 Roche Osteoporosis Therapeutics Introduction
13.3.4 Roche Revenue in Osteoporosis Therapeutics Business (2015-2020)
13.3.5 Roche Recent Development
13.4 Novartis
13.4.1 Novartis Company Details
13.4.2 Novartis Business Overview
13.4.3 Novartis Osteoporosis Therapeutics Introduction
13.4.4 Novartis Revenue in Osteoporosis Therapeutics Business (2015-2020)
13.4.5 Novartis Recent Development
13.5 Ono
13.5.1 Ono Company Details
13.5.2 Ono Business Overview
13.5.3 Ono Osteoporosis Therapeutics Introduction
13.5.4 Ono Revenue in Osteoporosis Therapeutics Business (2015-2020)
13.5.5 Ono Recent Development
13.6 Astellas Pharma
13.6.1 Astellas Pharma Company Details
13.6.2 Astellas Pharma Business Overview
13.6.3 Astellas Pharma Osteoporosis Therapeutics Introduction
13.6.4 Astellas Pharma Revenue in Osteoporosis Therapeutics Business (2015-2020)
13.6.5 Astellas Pharma Recent Development
13.7 Procter & Gamble
13.7.1 Procter & Gamble Company Details
13.7.2 Procter & Gamble Business Overview
13.7.3 Procter & Gamble Osteoporosis Therapeutics Introduction
13.7.4 Procter & Gamble Revenue in Osteoporosis Therapeutics Business (2015-2020)
13.7.5 Procter & Gamble Recent Development
13.8 Sumitomo Pharmaceuticals
13.8.1 Sumitomo Pharmaceuticals Company Details
13.8.2 Sumitomo Pharmaceuticals Business Overview
13.8.3 Sumitomo Pharmaceuticals Osteoporosis Therapeutics Introduction
13.8.4 Sumitomo Pharmaceuticals Revenue in Osteoporosis Therapeutics Business (2015-2020)
13.8.5 Sumitomo Pharmaceuticals Recent Development
13.9 Servier
13.9.1 Servier Company Details
13.9.2 Servier Business Overview
13.9.3 Servier Osteoporosis Therapeutics Introduction
13.9.4 Servier Revenue in Osteoporosis Therapeutics Business (2015-2020)
13.9.5 Servier Recent Development
13.10 Eli Lilly
13.10.1 Eli Lilly Company Details
13.10.2 Eli Lilly Business Overview
13.10.3 Eli Lilly Osteoporosis Therapeutics Introduction
13.10.4 Eli Lilly Revenue in Osteoporosis Therapeutics Business (2015-2020)
13.10.5 Eli Lilly Recent Development
13.11 Pfizer
10.11.1 Pfizer Company Details
10.11.2 Pfizer Business Overview
10.11.3 Pfizer Osteoporosis Therapeutics Introduction
10.11.4 Pfizer Revenue in Osteoporosis Therapeutics Business (2015-2020)
10.11.5 Pfizer Recent Development
13.12 Amgen
10.12.1 Amgen Company Details
10.12.2 Amgen Business Overview
10.12.3 Amgen Osteoporosis Therapeutics Introduction
10.12.4 Amgen Revenue in Osteoporosis Therapeutics Business (2015-2020)
10.12.5 Amgen Recent Development
13.13 Chugai
10.13.1 Chugai Company Details
10.13.2 Chugai Business Overview
10.13.3 Chugai Osteoporosis Therapeutics Introduction
10.13.4 Chugai Revenue in Osteoporosis Therapeutics Business (2015-2020)
10.13.5 Chugai Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Osteoporosis Therapeutics Key Market Segments
Table 2. Key Players Covered: Ranking by Osteoporosis Therapeutics Revenue
Table 3. Ranking of Global Top Osteoporosis Therapeutics Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Osteoporosis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Bisphosphonates
Table 6. Key Players of Hormones
Table 7. Key Players of Strontium Ranelate
Table 8. Key Players of Raloxifene
Table 9. Key Players of Denosumab
Table 10. Key Players of Others
Table 11. Global Osteoporosis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 12. Global Osteoporosis Therapeutics Market Size by Regions (US$ Million): 2020 VS 2026
Table 13. Global Osteoporosis Therapeutics Market Size by Regions (2015-2020) (US$ Million)
Table 14. Global Osteoporosis Therapeutics Market Share by Regions (2015-2020)
Table 15. Global Osteoporosis Therapeutics Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 16. Global Osteoporosis Therapeutics Market Share by Regions (2021-2026)
Table 17. Market Top Trends
Table 18. Key Drivers: Impact Analysis
Table 19. Key Challenges
Table 20. Osteoporosis Therapeutics Market Growth Strategy
Table 21. Main Points Interviewed from Key Osteoporosis Therapeutics Players
Table 22. Global Osteoporosis Therapeutics Revenue by Players (2015-2020) (Million US$)
Table 23. Global Osteoporosis Therapeutics Market Share by Players (2015-2020)
Table 24. Global Top Osteoporosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoporosis Therapeutics as of 2019)
Table 25. Global Osteoporosis Therapeutics by Players Market Concentration Ratio (CR5 and HHI)
Table 26. Key Players Headquarters and Area Served
Table 27. Key Players Osteoporosis Therapeutics Product Solution and Service
Table 28. Date of Enter into Osteoporosis Therapeutics Market
Table 29. Mergers & Acquisitions, Expansion Plans
Table 30. Global Osteoporosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 31. Global Osteoporosis Therapeutics Market Size Share by Type (2015-2020)
Table 32. Global Osteoporosis Therapeutics Revenue Market Share by Type (2021-2026)
Table 33. Global Osteoporosis Therapeutics Market Size Share by Application (2015-2020)
Table 34. Global Osteoporosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 35. Global Osteoporosis Therapeutics Market Size Share by Application (2021-2026)
Table 36. North America Key Players Osteoporosis Therapeutics Revenue (2019-2020) (Million US$)
Table 37. North America Key Players Osteoporosis Therapeutics Market Share (2019-2020)
Table 38. North America Osteoporosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 39. North America Osteoporosis Therapeutics Market Share by Type (2015-2020)
Table 40. North America Osteoporosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 41. North America Osteoporosis Therapeutics Market Share by Application (2015-2020)
Table 42. Europe Key Players Osteoporosis Therapeutics Revenue (2019-2020) (Million US$)
Table 43. Europe Key Players Osteoporosis Therapeutics Market Share (2019-2020)
Table 44. Europe Osteoporosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 45. Europe Osteoporosis Therapeutics Market Share by Type (2015-2020)
Table 46. Europe Osteoporosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 47. Europe Osteoporosis Therapeutics Market Share by Application (2015-2020)
Table 48. China Key Players Osteoporosis Therapeutics Revenue (2019-2020) (Million US$)
Table 49. China Key Players Osteoporosis Therapeutics Market Share (2019-2020)
Table 50. China Osteoporosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 51. China Osteoporosis Therapeutics Market Share by Type (2015-2020)
Table 52. China Osteoporosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 53. China Osteoporosis Therapeutics Market Share by Application (2015-2020)
Table 54. Japan Key Players Osteoporosis Therapeutics Revenue (2019-2020) (Million US$)
Table 55. Japan Key Players Osteoporosis Therapeutics Market Share (2019-2020)
Table 56. Japan Osteoporosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 57. Japan Osteoporosis Therapeutics Market Share by Type (2015-2020)
Table 58. Japan Osteoporosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 59. Japan Osteoporosis Therapeutics Market Share by Application (2015-2020)
Table 60. Southeast Asia Key Players Osteoporosis Therapeutics Revenue (2019-2020) (Million US$)
Table 61. Southeast Asia Key Players Osteoporosis Therapeutics Market Share (2019-2020)
Table 62. Southeast Asia Osteoporosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 63. Southeast Asia Osteoporosis Therapeutics Market Share by Type (2015-2020)
Table 64. Southeast Asia Osteoporosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 65. Southeast Asia Osteoporosis Therapeutics Market Share by Application (2015-2020)
Table 66. India Key Players Osteoporosis Therapeutics Revenue (2019-2020) (Million US$)
Table 67. India Key Players Osteoporosis Therapeutics Market Share (2019-2020)
Table 68. India Osteoporosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 69. India Osteoporosis Therapeutics Market Share by Type (2015-2020)
Table 70. India Osteoporosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 71. India Osteoporosis Therapeutics Market Share by Application (2015-2020)
Table 72. Central & South America Key Players Osteoporosis Therapeutics Revenue (2019-2020) (Million US$)
Table 73. Central & South America Key Players Osteoporosis Therapeutics Market Share (2019-2020)
Table 74. Central & South America Osteoporosis Therapeutics Market Size by Type (2015-2020) (Million US$)
Table 75. Central & South America Osteoporosis Therapeutics Market Share by Type (2015-2020)
Table 76. Central & South America Osteoporosis Therapeutics Market Size by Application (2015-2020) (Million US$)
Table 77. Central & South America Osteoporosis Therapeutics Market Share by Application (2015-2020)
Table 78. Warner Chilcott Company Details
Table 79. Warner Chilcott Business Overview
Table 80. Warner Chilcott Product
Table 81. Warner Chilcott Revenue in Osteoporosis Therapeutics Business (2015-2020) (Million US$)
Table 82. Warner Chilcott Recent Development
Table 83. Merck & Co. Company Details
Table 84. Merck & Co. Business Overview
Table 85. Merck & Co. Product
Table 86. Merck & Co. Revenue in Osteoporosis Therapeutics Business (2015-2020) (Million US$)
Table 87. Merck & Co. Recent Development
Table 88. Roche Company Details
Table 89. Roche Business Overview
Table 90. Roche Product
Table 91. Roche Revenue in Osteoporosis Therapeutics Business (2015-2020) (Million US$)
Table 92. Roche Recent Development
Table 93. Novartis Company Details
Table 94. Novartis Business Overview
Table 95. Novartis Product
Table 96. Novartis Revenue in Osteoporosis Therapeutics Business (2015-2020) (Million US$)
Table 97. Novartis Recent Development
Table 98. Ono Company Details
Table 99. Ono Business Overview
Table 100. Ono Product
Table 101. Ono Revenue in Osteoporosis Therapeutics Business (2015-2020) (Million US$)
Table 102. Ono Recent Development
Table 103. Astellas Pharma Company Details
Table 104. Astellas Pharma Business Overview
Table 105. Astellas Pharma Product
Table 106. Astellas Pharma Revenue in Osteoporosis Therapeutics Business (2015-2020) (Million US$)
Table 107. Astellas Pharma Recent Development
Table 108. Procter & Gamble Company Details
Table 109. Procter & Gamble Business Overview
Table 110. Procter & Gamble Product
Table 111. Procter & Gamble Revenue in Osteoporosis Therapeutics Business (2015-2020) (Million US$)
Table 112. Procter & Gamble Recent Development
Table 113. Sumitomo Pharmaceuticals Business Overview
Table 114. Sumitomo Pharmaceuticals Product
Table 115. Sumitomo Pharmaceuticals Company Details
Table 116. Sumitomo Pharmaceuticals Revenue in Osteoporosis Therapeutics Business (2015-2020) (Million US$)
Table 117. Sumitomo Pharmaceuticals Recent Development
Table 118. Servier Company Details
Table 119. Servier Business Overview
Table 120. Servier Product
Table 121. Servier Revenue in Osteoporosis Therapeutics Business (2015-2020) (Million US$)
Table 122. Servier Recent Development
Table 123. Eli Lilly Company Details
Table 124. Eli Lilly Business Overview
Table 125. Eli Lilly Product
Table 126. Eli Lilly Revenue in Osteoporosis Therapeutics Business (2015-2020) (Million US$)
Table 127. Eli Lilly Recent Development
Table 128. Pfizer Company Details
Table 129. Pfizer Business Overview
Table 130. Pfizer Product
Table 131. Pfizer Revenue in Osteoporosis Therapeutics Business (2015-2020) (Million US$)
Table 132. Pfizer Recent Development
Table 133. Amgen Company Details
Table 134. Amgen Business Overview
Table 135. Amgen Product
Table 136. Amgen Revenue in Osteoporosis Therapeutics Business (2015-2020) (Million US$)
Table 137. Amgen Recent Development
Table 138. Chugai Company Details
Table 139. Chugai Business Overview
Table 140. Chugai Product
Table 141. Chugai Revenue in Osteoporosis Therapeutics Business (2015-2020) (Million US$)
Table 142. Chugai Recent Development
Table 143. Research Programs/Design for This Report
Table 144. Key Data Information from Secondary Sources
Table 145. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Osteoporosis Therapeutics Market Share by Type: 2020 VS 2026
Figure 2. Bisphosphonates Features
Figure 3. Hormones Features
Figure 4. Strontium Ranelate Features
Figure 5. Raloxifene Features
Figure 6. Denosumab Features
Figure 7. Others Features
Figure 8. Global Osteoporosis Therapeutics Market Share by Application: 2020 VS 2026
Figure 9. Hospital Pharmacies Case Studies
Figure 10. Online Pharmacies Case Studies
Figure 11. Retail Pharmacies Case Studies
Figure 12. Osteoporosis Therapeutics Report Years Considered
Figure 13. Global Osteoporosis Therapeutics Market Size YoY Growth 2015-2026 (US$ Million)
Figure 14. Global Osteoporosis Therapeutics Market Share by Regions: 2020 VS 2026
Figure 15. Global Osteoporosis Therapeutics Market Share by Regions (2021-2026)
Figure 16. Porter's Five Forces Analysis
Figure 17. Global Osteoporosis Therapeutics Market Share by Players in 2019
Figure 18. Global Top Osteoporosis Therapeutics Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Osteoporosis Therapeutics as of 2019
Figure 19. The Top 10 and 5 Players Market Share by Osteoporosis Therapeutics Revenue in 2019
Figure 20. North America Osteoporosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Europe Osteoporosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. China Osteoporosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Japan Osteoporosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. Southeast Asia Osteoporosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. India Osteoporosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Central & South America Osteoporosis Therapeutics Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. Bottom-up and Top-down Approaches for This Report
Figure 28. Data Triangulation
Figure 29. Key Executives Interviewed
閉経後骨粗鬆症治療薬の世界市場（～2026年） Osteoporosis is a disease where increased bone weakness increases the risk of a broken bone. The postmenopausal osteoporosis therapeutics market is expected to register a fast growth over the forecast period owing to the increasing prevalence of postmenopausal osteoporosis disease. Market Analysis a…- 抗骨粗鬆症治療・骨折治癒の世界市場（～2026年） Osteoporosis disease is the most prevalent disease that occurs due to bone mineral density which causes heavy risk of fractures and bone fragility. The disease occurs mostly in spine, hip, shoulder and forearm.Hip fractures are most common as nearly one-third of patients lose mobility and need long-…
- B型肝炎治療薬の世界市場（～2026年） Market Analysis and Insights: Global Hepatitis B Therapeutics Market The global Hepatitis B Therapeutics market size is projected to reach US$ 2568.8 million by 2026, from US$ 2489 million in 2020, at a CAGR of 3.0%% during 2021-2026. Global Hepatitis B Therapeutics Scope and Market Size Hepatitis B…
- 産後うつ病治療薬の世界市場（～2026年） Postpartum depression is a prevalent disorder affecting many women of reproductive age. Mood stabilizing medications reduce the risk of postpartum bipolar depression relapse but no randomized controlled trials have examined their use in the acute or prophylactic treatment of postpartum bipolar depre…
- 睡眠障害治療薬の世界市場（～2026年） Sleep disorders result in a lack of deep and restorative sleep. The sleep disorder therapeutics market is expected to witness a high growth over the forecast period owing to the increasing prevalence of sleep disorder in modern times. Market Analysis and Insights: Global Sleep Disorder Therapeutics …